======= PAPSS2 ======= == Gene Information == * **Official Symbol**: PAPSS2 * **Official Name**: 3'-phosphoadenosine 5'-phosphosulfate synthase 2 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=9060|9060]] * **UniProt**: [[https://www.uniprot.org/uniprot/O95340|O95340]] * **Interactions**: [[https://thebiogrid.org/search.php?search=PAPSS2&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20PAPSS2|Open PubMed]] * **OMIM**: [[https://omim.org/entry/603005|Open OMIM]] == Function Summary == * **Entrez Summary**: Sulfation is a common modification of endogenous (lipids, proteins, and carbohydrates) and exogenous (xenobiotics and drugs) compounds. In mammals, the sulfate source is 3'-phosphoadenosine 5'-phosphosulfate (PAPS), created from ATP and inorganic sulfate. Two different tissue isoforms encoded by different genes synthesize PAPS. This gene encodes one of the two PAPS synthetases. Defects in this gene cause the Pakistani type of spondyloepimetaphyseal dysplasia. Two alternatively spliced transcript variants that encode different isoforms have been described for this gene. [provided by RefSeq, Jul 2008]. * **UniProt Summary**: Bifunctional enzyme with both ATP sulfurylase and APS kinase activity, which mediates two steps in the sulfate activation pathway. The first step is the transfer of a sulfate group to ATP to yield adenosine 5'-phosphosulfate (APS), and the second step is the transfer of a phosphate group from ATP to APS yielding 3'-phosphoadenylylsulfate (PAPS: activated sulfate donor used by sulfotransferase). In mammals, PAPS is the sole source of sulfate; APS appears to be only an intermediate in the sulfate- activation pathway. May have a important role in skeletogenesis during postnatal growth (By similarity). {ECO:0000250}. |APS kinase| |ATP-sulfurylase| |adenylylsulfate kinase activity| |sulfate adenylyltransferase (ATP) activity| |sulfate assimilation| |3-phosphoadenosine 5-phosphosulfate biosynthetic process| |purine ribonucleoside bisphosphate biosynthetic process| |nucleotidyltransferase activity| |3-phosphoadenosine 5-phosphosulfate metabolic process| |purine ribonucleoside bisphosphate metabolic process| |ribonucleoside bisphosphate biosynthetic process| |purine nucleoside bisphosphate biosynthetic process| |nucleoside bisphosphate biosynthetic process| |nucleoside bisphosphate metabolic process| |purine nucleoside bisphosphate metabolic process| |ribonucleoside bisphosphate metabolic process| |purine ribonucleotide biosynthetic process| |purine nucleotide biosynthetic process| |ribonucleotide biosynthetic process| |ribose phosphate biosynthetic process| |purine-containing compound biosynthetic process| |sulfur compound biosynthetic process| |bone development| |nucleotide biosynthetic process| |nucleoside phosphate biosynthetic process| |blood coagulation| |coagulation| |hemostasis| |purine ribonucleotide metabolic process| |ribonucleotide metabolic process| |purine nucleotide metabolic process| |ribose phosphate metabolic process| |sulfur compound metabolic process| |purine-containing compound metabolic process| |nucleotide metabolic process| |nucleoside phosphate metabolic process| |wound healing| |skeletal system development| |regulation of body fluid levels| |organophosphate biosynthetic process| |nucleobase-containing small molecule metabolic process| |response to wounding| |carbohydrate derivative biosynthetic process| |organophosphate metabolic process| |oxoacid metabolic process| |organic acid metabolic process| |carbohydrate derivative metabolic process| |nucleobase-containing compound biosynthetic process| |heterocycle biosynthetic process| |aromatic compound biosynthetic process| |phosphorylation| |organic cyclic compound biosynthetic process| |organonitrogen compound biosynthetic process| |ATP binding| |cellular nitrogen compound biosynthetic process| |small molecule metabolic process| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp227|Cryptotanshinone 12μM R05 exp227]]|-2| |[[:results:exp31|Rifampicin 1μM R00 exp31]]|-1.86| |[[:results:exp278|CVT-10216 0.1μM R06 exp278]]|-1.85| |[[:results:exp108|Vinblastine 0.2μM R03 exp108]]|-1.8| No correlation found to any other genes in chemogenomics. Global Fraction of Cell Lines Where Essential: 0/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 11723 * **Expression level (log2 read counts)**: 0.78 {{:chemogenomics:nalm6 dist.png?nolink |}}